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TITLE 
 
Routine changing of intravascular administration-sets does not reduce colonization or 
infection in central venous catheters. 
 
 
ABSTRACT (250 words) 
 
Objective: To determine the effect of routine intravascular administration-set changes 
on central venous catheter (CVC) colonization and catheter related bacteremia 
(CRB). 
 
Design: Prospective, randomised controlled trial 
 
Setting: 18-bed ICU in a University-affiliated, tertiary referral hospital. 
 
Participants: 404 chlorhexidine and silver sulfadiazine coated multi-lumen CVCs from 
251 intensive care unit (ICU) patients. 
 
Interventions: After ethical approval, CVCs inserted in ICU and in situ on Day 4 were 
randomised to have their administration-sets changed on Day 4 (n = 203) or not at all 
(n = 201). Fluid container and blood product administration-set use was limited to 24 
hours. CVCs were removed (Day 7, not required or suspected infection), and 
cultured for colonization (≥ 15 cfu). Medical and laboratory staff were blinded. CRB 
was diagnosed by a blinded intensivist using strict definitions. Data was collected on; 
catheter life, CVC site, APACHE II score, patient age, diagnosis, hyperglycemia, 
hypoalbuminemia, immune status, number of fluid containers and intravenous 
injections, propofol, blood, TPN or lipid infusion. 
 
Results: There were 10 colonized CVCs in the set change group and 19 in the no 
change group. This was not a statistically significant difference on Kaplan Meier 
survival analysis (Effect Size = 0.09, Log Rank = 0.87, df = 1, p = 0.35). There were 3 
cases of CRB per group. Logistic regression found that burns diagnosis and 
increased ICU stay were the only factors that significantly predicted colonization (p < 
0.001). 
 
Conclusions: Intravenous administration-sets can be used for 7-days. Routine 
administration-set changes are unnecessary before this time.  
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TITLE 
 
Routine changing of intravascular administration-sets does not reduce colonization or 
infection in central venous catheters. 
 
INTRODUCTION     
 
Many hospitalised patients require an intravascular catheter for the administration of 
fluid, nutrition and medication, for intravascular monitoring or for ease of blood 
sampling. Intravascular catheters break the body’s natural defence barrier (the skin), 
and so put the patient at risk of hospital-acquired infection. Catheter-related infection 
is devastating, with increased suffering and risk of death for patients and increased 
institutional costs due to the increased length and complexity of the hospital 
admission and associated costs. A case-controlled study observed patients with 
catheter related bacteremia (CRB) to have an attributable mortality of 25%, and an 
additional intensive care unit (ICU) stay of 6.5 days; the cost of this was calculated at 
U.S.$28,690 (1994 values).1 Clinicians use many strategies that are believed to 
minimize infection risk including the routine change of intravascular administration-
sets more frequently than the catheter itself is changed.  
 
The practice of routinely changing intravascular administration-sets is not evidence-
based. Prior to the 1970s, intravenous therapy was not widespread and 
administration-sets seem to have been used until they were no longer required. The 
procedure of routine replacement of administration-sets developed in response to the 
early 1970s U.S. epidemic of catheter-related bacteremia, which occurred due to 
manufacturer contaminated intravenous fluid.2,3 Despite the seeming unrelated 
nature to the cause of the problem, the solution of routine replacement of 
administration-sets and fluids every 24 hours was advocated,4 and almost universally 
implemented.  
 
Over the past three decades, researchers have slowly challenged the premise that 
daily set changes are required. Several studies have compared different time-
intervals for changing the sets.  Changes at 48 hours were found equi-efficacious as 
at 24 hours,5-8 changes at 72 hours were observed to be equal to those at 48 
hours,9,10 or at 24 hours,11 set changes at 96hrs were found equivalent to changes at 
48hrs,12,13 changes “between Day 4 and Day 7” found equivalent to change at Day 
3,14 and changes at 24, 48, 72, 96 and 120 hours found to be indistinguishable from 
each other.15 It is interesting that all these studies were based on the assumption that 
routine administration-set changes prevent infection: the focus was to find an “ideal” 
time-interval for performing administration-set changes rather than questioning the 
efficacy of the practice per se. 
 
The most recent Centers for Disease Control (CDC) Guidelines recognise the lack of 
evidence for this procedure and advise the changing of administration-sets “no more 
frequently than every 72 hours”.16 In many clinical settings this seems to have been 
interpreted as “change at 72 hours”, although there are increasing anecdotal reports 
of institutions extending use of administration-sets to 7 days, motivated by the cost 
savings achieved.   
 
The issue of total parenteral nutrition (TPN) and lipid administration-sets is a slightly 
more complicated issue than for standard solutions. The CDC advocates 24-hourly 
changes for TPN and lipid sets, perceiving that more frequent set changes are 
required than for other solutions, in order to prevent infection. Some studies have 
found TPN to behave no differently to other fluids,5,12 or that longer intervals between 
set changes are associated with lower infection than more frequent changes.11 One 
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study found a reduced infection rate with more frequent lipid administration-set 
changes in a neonatal population, a subgroup that may perform differently.17 This 
study along with many others on the topic, sampled administration-set fluid but not 
the catheter itself, which makes assessment of the relationship between duration of 
administration-set use and catheter colonization or CRB impossible. 
 
The present study examined whether routine administration-set changes, (including 
TPN and lipid sets), resulted in decreased colonization or infection when compared 
with central venous catheters that had their original administration-sets left intact for 
the duration of CVC usage.  
 
 
METHODS    
 
Study Setting  
 
The study took place in an 18 bed ICU in a 700-bed tertiary referral hospital. It should 
be noted for this study, the hospital is a regional centre for burns and bone marrow 
transplantation. As in most Australian ICUs, the unit has dedicated staffing, both 
medical and nursing. The medical staff consist of full-time Intensivists, “senior 
registrars” (24 month appointments) and rotating registrars from disciplines of 
medicine, surgery, emergency medicine and anesthesiology. The ICU medical staff 
have sole admitting, discharge and prescribing rights.  The unit has approximately 
80% bed occupancy and over 1200 patients are admitted per annum with an average 
length of stay of just under 4 days. 
 
Study Sample 
 
A variety of CVCs were used in the ICU prior to the study, however unit policy was 
standardised during the research period. The ARROWgard Blue 3 or 4 lumen 
chlorhexidine and silver sulfadiazine coated CVC (Arrow International Inc, 
Pennsylvania, U.S.A.) was used for all catheterizations. The only exclusion to this 
was for patients who were known to be allergic to the catheter materials, however no 
such patients were admitted. Between February 1999 and January 2000, all CVCs 
remaining in situ on Day 4 (day of insertion being Day 1) were randomised into the 
study. A computerised random-number generator was used to assign each CVC to 
receive either a routine set change (experimental group) or to have the original 
administration-set left intact for the duration of CVC life (control group). Eligible 
subjects were entered sequentially and individual patients could enter the study more 
than once if they had multiple catheterizations. The unit of measurement was the 
individual catheter not the patient. 
 
Catheter Care 
 
CVC insertion was by ICU medical staff, including Intensivists, senior registrars and 
registrars. Insertion was undertaken in the ICU using strict aseptic technique and 
always at a new skin site, with new intravenous fluids and administration-sets 
connected. Catheters were non-tunnelled but were secured to the skin by two 
sutures.  
 
For the experimental group, set changes were performed on Day 4 at approximately 
72 hrs (+/- 12 hours) post-insertion. ICU registered nurses (RNs) prepared 
administration-sets using an aseptic technique, involving a sterile drape and sterile 
gloves following a clinical (2 minute) handwash. Administration-set changes were 
performed using an aseptic technique of clinical handwash, sterile gloves, clean 
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plastic apron, sterile dressing packs, sterile drape under the connection area and 
chlorhexidine swabbing of connection sites prior to administration-set change. 
 
For the purposes of this study, the administration-set was defined as all connections 
between the CVC and the fluid reservoir, including: intravascular tubing, fluid 
burettes, extension tubing, and pressure monitor transducers. Fluid reservoirs (i.e. 
fluid bags, bottles and syringes) were also changed at the time of administration-set 
change. Fluid reservoirs were additionally changed within 24 hours of opening. 
Administration-sets used to administer blood or blood products were discarded after 
each transfusion episode. However, administration-sets used for total parenteral 
nutrition, lipids and propofol infusions were included in the study, that is they were 
changed only at Day-4 or were left intact. The composition of administration-sets was 
not static. If a new infusion was required or an existing infusion no longer needed, 
then these were assembled and connected or disconnected using a non-touch 
technique.  
 
All other aspects of CVC management apart from administration-set changes were 
equal between groups. Dressing changes (Opsite IV3000, Smith and Nephew 
Medical Ltd., Hull, U.K.) were performed routinely on Day 4 for all patients and 
additionally if the dressing was soiled, loose or had a collection of blood beneath it. 
Medical staff ordered the removal of CVCs routinely on Day 7 or earlier if the patient 
died, did not require the CVC or was suspected of CVC infection. Medical staff were 
blinded to treatment group so that their decision to order catheter removal, blood or 
other cultures was not biased. 
 
Catheter Culture 
 
Removal of the CVC and preparation of tip specimen was performed by ICU RNs 
using a clinical handwash, sterile gloves, clean plastic apron, sterile dressing pack 
and sterile drape. The insertion site was swabbed 5 times with chlorhexidine in ever 
increasing circles and allowed to dry. The stitches were cut with a sterile stitch cutter, 
the CVC was removed and the distal portion (approximately 3cm) was severed with 
sterile scissors and placed in a sterile specimen jar. CVC tips were sent to the 
microbiology lab for culture and speciation via semiquantitative technique.18 The 
laboratory staff were blinded to treatment group so that the results were unbiased.  
 
Data Collection 
 
Research nurses’ monitored adherence to the protocol and collected data on 
microbiology results, presence of the Systemic Inflammatory Response Syndrome 
(SIRS),19 patient demographics and other potential risk factors for CVC infection. A 
blinded intensivist reviewed microbiological results (catheter tip cultures, blood 
cultures and cultures of other sites) and SIRS using strict definitions20 to diagnose 
the presence or absence of CRB.  
 
Definitions 
 
A positive catheter tip culture was defined as the growth of at least one species of 15 
or greater colony forming units. Catheter Related Bacteremia was diagnosed as 
definite, probable (types 1 and 2 combined), possible or absent using previously 
described definitions.20 These definitions were developed to address the difficulties 
associated with the application of the more commonly used CDC definition of 
Catheter Related Bloodstream Infection (CRBSI) in situations such as the ICU, where 
patients are difficult to diagnose due to multiple concurrent disease processes and/or 
colonized sites, and unavailable or incomplete microbiological data. The “Definite” 
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and “Possible” categories used in this study combine to equate with the CDC 
definition of CRBSI, a fact that will facilitate comparison between this and other 
studies. See Table 1. 
 
Insert Table 1 here 
 
Ethical Considerations 
 
The study was approved by both the Hospital and the University Human Research 
Ethics Committees. Individual consent was waived considering the legal 
incompetence of patients. State legislation precluded relatives from considering legal 
consent, however relatives were notified of enrolment, provided with information 
about the study and were able to ask questions or to request their relative’s 
withdrawal without penalty.  
 
Statistical Analysis 
 
Considering the varied duration of catheterization the primary analysis of colonization 
between groups was tested using Kaplan-Meier survival curve with Log-rank test. 
The distribution between groups of variables considered risk factors for catheter 
colonization were tested to assess for bias. Proportions were tested with chi-square. 
Differences in mean scores on continuous variables were tested with t-test. Logistic 
regression modelling was performed to analyse the influence of potentially 
confounding variables. A total of 29 CVCs (7.1%) were not cultured due to factors 
such as; catheter contaminated on removal by staff or patient, tip lost in transit to 
laboratory, or catheter left in situ for coronial autopsy. These were equally distributed 
across treatment groups (set change group n = 14, no change n = 15). All analysis 
was undertaken used the Statistical Package for the Social Sciences version 10.0 
(SPSS, Chicago, U.S.A.). 
 
 
RESULTS     
 
Sample 
 
A total of 404 CVCs were enrolled into the study from 251 patients. Of these, 157 
patients contributed 1 CVC to the study, the others having multiple catheters. There 
were 24,918 hours of catheter life in the set change group and 25,384 hours in the no 
change group. Randomisation was successful in distributing most demographic 
variables and risk factors for CVC infection equally between groups. See Table 2. 
The only statistically significantly difference between groups was for age and the 
number of intravenous injections. It is unlikely that these differences were clinically 
significant, comprising a mean difference of 5 years in age and 6 injections per CVC. 
 
Insert Table 2 here 
 
Colonization 
 
Of the 375 catheter tips cultured, there were 10 colonized tips in the set change 
group and 19 in the no set change group. This difference was not statistically 
significant (Kaplan Meier survival analysis, Log Rank = 0.87, df = 1, p = 0.3505). See 
Figure 1. 
 
The 29 colonized tips belonged to 23 patients. Four patients had multiple colonized 
tips including two patients with two colonized tips, and two with three colonized tips. 
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Of these four patients with multiple colonized tips, three had other non-colonized tips 
in the study. Of the other 19 patients with a single colonized tip, 13 had at least one 
other non-colonized tip in the study. A first-catheter-per-patient analysis was also 
performed and found no difference in colonization between the study groups (Kaplan-
Meier with Log Rank = 2.63, df = 1, p = 0.1047). 
 
There was a significant difference in colonization rates by catheter site. Subclavian 
lines were colonized in only 5.0% of cases, jugular lines in 9.4% of cases and 
femoral lines in 20.8% of catheters (chi-square 14.48, df = 2, p = 0.001). There were 
also statistically significant differences in colonization by diagnostic group (chi-square 
39.15, df = 3, p < 0.001) with neurological patients having the lowest (zero) incidence 
and burns patients the highest (29%). Surgical/trauma and medical patients had 
more moderate levels at 5% and 7% respectively. 
 
Insert Figure 1 here 
 
Catheter Related Bacteremia 
 
Of the 404 patients, there were 3 cases (1 definite, 1 probable and 1 possible) of 
CRB in the experimental (set change) group and 3 (2 probable and 1 possible) in the 
control (no change) group.  Implicated organisms were from the Acinetobacter, 
Staphylococcus, Pseudomonas, Enterobacter and Klebsiella species. The difference 
in survival from CRB rates between groups was not statistically significant (Kaplan 
Meier with Log Rank test, p = 0.862). See Figure 2   
 
Insert Figure 2 here 
 
Logistic Regression Model 
 
Bivariate analysis was performed to examine significant associations between 
catheter colonization and a range of risk factors. Factors that were not associated 
with colonization of the catheter tip included: APACHE II score on ICU admission, 
number of intravenous fluid bags infused, hours of catheter life, medical seniority of 
catheter inserter, number of lumens, immunocompromised status, hyperglycemia 
and propofol, total parenteral nutrition, or lipid transfusion,  
 
The following factors were found to be significantly associated with colonized 
catheters on bivariate analysis: age, burns diagnosis, ICU days on catheter insertion, 
hospital days on catheter insertion, APACHE II on day of insertion, blood transfusion, 
hypoalbuminemia, removal for suspected CRB, site of catheter, and subsequent 
catheters in multiply catheterized patients. 
 
To test these risk factors in a multivariate model, a forward step-wise logistic 
regression was conducted. Only two risk factors entered the model; burns diagnosis 
(OR 6.845, 95%CI 2.96 - 15.83, p < 0.001) and increased ICU days on catheter 
insertion (OR1.080, 95%CI 1.035 - 1.127, p < 0.001). 
 
 
DISCUSSION     
 
This study did not find a statistically significant difference in colonization or CRB rates 
between catheters whose administration-sets were routinely replaced on Day 4 and 
those whose administration-sets were not replaced at all. The study involved central 
venous catheters from ICU patients, including burns patients, immunosuppressed 
patients and those receiving TPN and lipid therapy. These groups have been 
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identified in the literature as at high risk of catheter colonization and infection.8,21,22 
Routine changing of administration-sets was of no benefit to this high-risk sample 
and as such, it is unlikely it would have any effect in lower risk populations such as 
ward patients or other types of intravascular catheters such as arterial lines.  
 
The sample size had 80% power to detect an effect size on colonization of 0.14 at an 
alpha of 0.05. The effect size observed was 0.09, a small effect size as per Cohen’s 
criteria.23 This equates to the observed incidence of 5.3% colonization in the set 
change group and 10.2% in the no set change group, a difference that was not 
statistically significant. It is possible that a larger sample may have detected a 
significant difference, however it could only have been at most at a slightly larger 
effect size, still in the range of small effect, that is, in the realm of 0.10 - 0.13, and it is 
questionable whether this would be of clinical significance. It must be remembered 
that colonization in itself is harmless and relatively common, with incidence quoted in 
the literature much higher than the data reported here in either group. A meta-
analysis of 12 studies assessing the efficacy of the chlorhexidine-silver-sulphadiazine 
catheters (identical to those used in this study) found the colonisation rate to be a 
mean 16.2% with a range of 0 - 39.7%.24 Some level of colonisation should be 
considered unavoidable, although at what level is debatable. A study that cultured 
CVCs immediately after insertion found that 16% were already colonized despite skin 
disinfection and aseptic insertion technique.25 If an acceptable or at least an average 
colonization rate is at around the 16% rate, then any potential significant difference 
related to administration-set changes that would have been observed in a larger 
study would be unlikely to be of clinical significance. Vitally, colonization was a 
surrogate endpoint for CRB due to the statistical difficulties of using the infrequently 
diagnosed CRB, and the known potential for colonized catheters to progress over 
time to infection.22,26 In interpreting the results of this study, it is important to note that 
CRB is the actual phenomenon of interest and that the incidence of this diagnosis 
was identical (1.5% of catheters or 3 cases per 1000 catheter days) in the two 
groups.  This incidence is at the lower end of the reported figures in the literature.27 
 
Colonization incidence was 10.4 per 1000 catheter days in the experimental group 
and 20.1 per 1000 catheter days in the control group, a difference that was not 
significant even on crude analysis (OR experimental group 0.51, 95%CI 0.24 - 1.09, 
p = 0.34). It is important to note that the primary statistical analysis used was the 
more sophisticated survival modelling, which accounted for not only the magnitude of 
the incidence of colonization/CRB between groups but also how long the implicated 
catheter had been in situ for when the colonization/CRB occurred. This is an 
important consideration in this type of study; for example a catheter that becomes 
colonized on Day 4 is of greater concern than one that is colonized on Day 7. 
 
There have been 16 studies into the appropriate duration of administration-set use.5-
15,17,28-31 These studies have been undertaken in a variety of populations and catheter 
types, and all, except one,17 found an equal or a reduced infection risk the longer that 
administration-sets were left unchanged. The one study that did find benefit had 
somewhat conflicting results in that a reduced contamination rate in the fluid itself 
was found after 72 hour changes versus 24 hour changes, however no difference 
was found in infusate related bacteremia between the groups (catheter colonization 
rates were not reported).17 Interestingly, all research studies to date have focussed 
on the identification of an optimal time-point for routine administration-set 
replacement to occur; that is, they have assumed that one exists.5-15,17,28-31 
Occasionally it is noted that there may not be an ideal time-point, and the practice 
may have no effect at all.9,28 Our study is important, as it is the first to address this 
question, by having an experimental group who were not subjected to administration-
set replacement at any time-point (in this case, over the 7-day catheter life). The 
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practice of routinely replacing administration-sets has become entrenched in clinical 
ritual over the last three decades and attempts to reduce or disband the practice are 
difficult despite the absence of definitive evidence to support it, and a growing body 
of evidence to suggest that it is ineffective. The 1996 CDC guidelines are frequently 
misquoted to support the procedure when they do not recommend the procedure per 
se, merely stating that it should occur “no more frequently than at 72 hour 
intervals”.16  
 
The finding of this study, that routine administration-set changes had no benefit, 
seems to be congruent with the pathogenesis of catheter colonization. The four 
potential routes of catheter colonization have been identified as the skin site, 
hematogenous seeding from distant sites, a contaminated catheter hub or 
contaminated intravenous fluid.22,32 Of these, colonization via the skin site is 
recognised as the dominant route of colonization for short term (in situ < 10 days) 
catheters,33 and may occur as early as at catheter insertion, that is, before the 
administration-sets are even connected.25 However, skin site colonization as well as 
colonization due to hematological seeding, could not possibly be prevented by 
administration-set changes, as the administration-set does not involve these 
pathways. In contrast, replacement of the administration-set could theoretically 
influence catheter hub and intravenous fluid contamination. Traditionally it has been 
assumed that replacement of sets would decrease circuit contamination however it 
seems equally, if not more likely, that the potential for contamination could be 
increased. Administration-sets connect both to the catheter hub and to intravenous 
fluid containers; routine replacement involves additional manual handling of these 
structures and a break to the circuit, thus providing an opportunity for microorganism 
entry.28 
 
Extrinsic (post-manufacturer) intravenous fluid contamination infrequently occurs and 
colonization of the fluid does not necessarily progress to colonization or infection.16 
The risk of contamination of the fluid container may be different to the administration-
set proper (the “giving sets”, burettes, connection tubing etc) as it involves a larger 
volume of more static fluid, in contrast to the small volume dynamic fluid in the set 
itself. It seems logical that the less times the circuit is disconnected to attach a fluid 
container, the lower the infection risk, however it is unclear from many of the previous 
studies into the duration of administration-set use, whether or not the intravenous 
fluid container was considered part of the administration-set and tested for prolonged 
use. The CDC gives no recommendation for the hang-time of intravenous fluids 
stating that this is an unresolved issue, except for TPN and lipid therapy which it 
advises should be completed within 24 and 12 hours respectively.16 In this study we 
replaced all intravenous fluid containers within 24 hours of opening so as to isolate 
the effect of prolonged use of the administration-set proper, from that of the 
intravenous fluid container. 
 
The results of this study are not surprising considering the clinical approach to 
administration-set integrity during the total catheterization period instead of merely at 
the routine set change. Administration-set configurations are not static throughout the 
catheterization period, but rather are manipulated frequently in the ICU environment 
(to add, remove or reconfigure infusions, to replace a fluid container or to give a 
medication). The standard techniques used for these manipulations should involve 
handwashing or at least hand alcohol solution and the set should be decontaminated 
with chlorhexidine, iodine or 70% alcohol before and after the set manipulation.16,26 
However, in the real world, the techniques used by staff are often divergent and may 
be less than aseptic.8 Adherence to rigorous sterile technique on insertion and at 
every manipulation of the circuit would probably have a more reliable effect on 
infection rates than a reliance on replacing the administration-sets at routine intervals 
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in the belief that this will “resterilise” the circuit after the questionable techniques 
used in between.8,34 
 
Before applying the results of this study to other populations, there are some 
important points to consider. It should be noted that the study design involved the 
removal of administration-sets used to deliver blood products once the transfusion 
was complete (< 24 hours) and the results therefore do not support extending the 
duration of use of blood product administration-sets. Other factors to consider in 
applying the results of this study include the study population of antimicrobial CVCs 
which are known to reduce colonization over plain catheters,24,33,35 but may not be as 
effective as antibiotic catheters, especially in longer term CVCs in situ for greater 
than 7 days.36-38 The caution of previous commentators on the issue of extending 
administration-set use should be noted; namely that results from studies that are 
undertaken in Western, research-oriented, tertiary-care centres (such as ours) may 
be influenced by a more meticulous standard of catheter care that may not be 
achieved in other settings.39,40 It is possible that routine change of administration-sets 
may have an effect in other settings although it is difficult to imagine that the scale of 
an effect could be even close to that achievable by simple techniques such as 
aseptic approach and stringent handwashing, or at a more sophisticated level, the 
use of antimicrobial catheters.  
 
The results of the study suggest that routine administration-set changes are 
ineffectual at any time point, however until a multi-centre, randomised controlled trial 
confirms these results, or assesses use beyond one week, it would be prudent to 
limit administration-set use to 7 days rather than for an unlimited time-frame. The 
study included catheters in situ for 52 - 196 hours (mean 124.5 hours), with a 
significant proportion (25%) removed on or after catheter Day 7. The results indicate 
that routine administration-set changes are unnecessary for catheters in situ for 
approximately one week, however the effect after this time has not been assessed. 
The ICU policy was to remove CVCs on Day 7, however 12 study catheters were in 
situ for a longer period. Of these, 3 were in the routine set change group and were 
not colonized, compared with 3 colonized lines out of the 9 catheters in the no-
change group. The 3 colonized lines were not associated with CRB diagnosis. Due to 
the small amount of catheters subjected to this timeframe, no conclusion can be 
drawn from this observation. It may indicate a trend to effectiveness of 
administration-set changes at the Day 7 time point, but more probably reflects the 
known tendency of catheters to be colonized after this length of time.26,38,41   
 
An issue that is often overlooked in this area is the effect of extended use on the 
actual physical condition of the administration-set. Recent data on the testing of 
administration-sets for 7 days of continuous use found them to remain accurate and 
in good physical condition.42 Beyond, this time, the durability of the materials is 
unknown. From an infection perspective, this study is the third to evaluate, and 
support, administration-set usage for 7 days. A study by Chen et al, to date only 
published in abstract form, reported no difference in colonization rates of 332 CVCs 
in a general ICU whose administration-sets were randomly replaced at 72 or 168 
hours (1 week).43 Raad, Hanna and colleagues studied 512 oncology patients whose 
CVCs were randomised to have the administration-sets replaced either within 3 days 
or between 4 and 7 days of placement.14 The study design resulted in only a small 
proportion of the sample having administration-sets used for 7 days (approximately 
25). Catheter colonization rates were not reported, however no statistically significant 
difference in infusate-related bacteremia (IRB) was found between the groups and it 
was noted that all patients with IRB were receiving interleukin-2, a medication not 
used in our own study group.  
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Routine administration-set changes are costly to perform at up to A$300 per 
procedure in terms of equipment alone. Extension of administration-set usage 
duration to 7 days would result in significant cost savings, less environmental waste 
and allow nursing time to be redirected to other patient care, education or research 
activities. The exact nature of current practice is unknown but varies greatly. In a 
survey of Australian, U.S. and Canadian hospitals, approximately half were changing 
administration-sets < 96 hourly, yet 22% were already using the sets for one week 
(Unpublished data, Rickard C, Ph D Candidate, June, 2000). 
 
The ICU environment attracts staff who enjoy a technological and highly procedural 
environment. A Heideggerian hermeneutic study asked what the meaning of caring in 
the intensive care unit was to nurses and reported one of the major themes as “being 
busy”.44 The complex performance of a routine administration-set change 
(colloquially termed a “line change”) has attained the status of a ritual and as such is 
psychologically difficult to reduce or disband, perhaps due to health care 
professionals feeling that “doing something” must be more effective than not doing it. 
The evidence based practice movement seeks to overcome ritualistic and historically 
based care with the implementation of care that is scientifically proven to be effective. 
The results of this study suggest that evidence based practice will be achieved by 
extending intravascular administration-set use to 7 days and for future research to 
evaluate longer timeframes. 
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Tables 
 
Table 1 
Definitions of Catheter Related Bacteremia20 
 
Findings Definite 
CRB 
 
Probable 
CRB (Type 1) 
Probable 
CRB (Type 2) 
Possible 
CRB 
Catheter Tip + + + - 
Blood culture + + - + 
SIRS with 
defervescence 
+/- +/- + + 
Colonization at 
other sites 
- + - - 
Infection at 
other sites 
- - - - 
Catheter related bacteremia: CRB, Systemic inflammatory Response Syndrome: SIRS, 
Positive culture result: +, Negative or missing result: - 
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Table 2 
Comparison of experimental (routine administration-set change) and control 
(no administration-set change) groups 
 
 Set Change 
 
No Set 
Change 
p 
value 
Hours in situ per CVC (mean +/- SD) 122.75 (26.81) 126.29 (29.59) NS 
Male (n) 120 133 NS 
Age (mean years +/- SD) 55.06 (18.66) 49.78 (19.79) 0.006 
APACHE II admit (mean +/- SD) 20.11 (6.74) 20.22 (7.25) NS 
APACHE II insert (mean +/- SD) 17.46 (6.78) 17.88 (7.29) NS 
ICU days at insertion (mean +/- SD) 6.04 (7.67) 6.03 (6.47) NS 
Hospital day at insertion (mean +/- SD) 7.95 (9.33) 9.84 (12.05) NS 
Site - subclavian/jugular/femoral (n) 139/37/24 138/30/31 NS 
Fluid bag changes (mean +/- SD) 55.13 (28.84) 59.23 (31.54) NS 
Injections through set (mean +/- SD) 53.74 (27.49) 59.69 (28.37) 0.033 
Immunocompromised (n) 7 15 NS 
Hypoalbuminemic (n) 64 69 NS 
Hyperglycemic (n) 4 3 NS 
Propofol Transfusion (n) 66 66 NS 
TPN Transfusion (n) 36 30 NS 
Blood Transfusion (n) 107 108 NS 
Lipid Transfusion (n) 36 31 NS 
Lumens – triple/quadruple (n) 195/8 192/9 NS 
Inserted by registrar 120 131 NS 
Reason for CVC removal (n)   
Routine (Day 7) 94 94 
Not required 59 62 
Suspected CRB 21 16 
Patient died 17 15 
Malfunction 7 10 
Other 5 4 
NS 
Diagnosis   
Medical 66 82 
Neuro 51 39 
Emergency Surgery 37 25 
Burns 25 28 
Trauma 17 20 
Elective Surgery 7 7 
NS 
Catheter order number   
First 126 125 
Second 45 48 
Third 21 17 
Fourth or more 11 11 
NS 
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Figures 
 
Figure 1.  
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Figure 2.  
Survival Functions
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Figure Legends 
 
Figure 1  
Survival curve for catheters to remain free of colonization by treatment group 
 
Figure 2 
Survival curve for catheters to remain free of catheter related bacteremia by 
treatment group 
